Principal Investigator
Nicolas Yannuzzi
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210404
Clinical Trial Summary
A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical
Study to Evaluate the Efficacy and Safety of RGX-314 Gene
Therapy in Participants with nAMD (ATMOSPHERE)
Phase
Phase II/III
Funding Agency/Sponsor
Intramural
Disease
Retina
Contact Information
Study Contact
Marlene Perez
Phone Number
+1 (305) 4824309
Email
mcolon@miami.edu